Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2008
07/08/2008CA2710043A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/08/2008CA2432131C Pyrazole compounds useful as protein kinase inhibitors
07/03/2008WO2008080134A2 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
07/03/2008WO2008079907A1 Compositions and methods for inhibition of the jak pathway
07/03/2008WO2008079787A2 Glucokinase activators
07/03/2008WO2008079687A1 Novel compounds as cannabinoid receptor ligands and uses thereof
07/03/2008WO2008079292A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
07/03/2008WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors
07/03/2008WO2008060927A3 Hepatitis c virus inhibitors
07/03/2008WO2008060927A2 Hepatitis c virus inhibitors
07/03/2008WO2008049919A3 Rho kinase inhibitors
07/03/2008WO2008043533A3 Acyl aminoimidazoles and acyl aminothiazoles
07/03/2008WO2008024980A3 Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives
07/03/2008WO2008019030A3 Modified azole compounds as antiinfective agents
07/03/2008WO2008002956A3 Thiazoline and oxazoline derivatives and their methods of use
07/03/2008WO2007143434A3 Indazole and isoindole derivatives as glucokinase activating agents
07/03/2008WO2007137417A8 Heterocyclic compounds as calcium channel blockers
07/03/2008WO2007054783A3 Compositions and methods for treating thrombocytopenia
07/03/2008US20080161581 Synthetic methodology for the reductive alkylation at the c-3 position of indoles
07/03/2008US20080161358 Cyanoamide Compounds Useful as Malonyl-COA Decarboxylase Inhibitors
07/03/2008US20080161353 8-Hydroxy quinoline derivatives
07/03/2008US20080161322 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease
07/03/2008US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
07/03/2008US20080161297 Rho kinase inhibitors
07/03/2008CA2673370A1 Substituted acetophenones useful as pde4 inhibitors
07/03/2008CA2673003A1 Quinazolines for pdk1 inhibition
07/03/2008CA2672088A1 Glucokinase activator
07/02/2008EP1939213A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
07/02/2008EP1939189A1 Derivative having ppar agonistic activity
07/02/2008EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents
07/02/2008EP1939185A1 New types of hetaryl-phenylendiamin-pyrimidines as protein kinase inhibitors for the treatment of cancer
07/02/2008EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
07/02/2008EP1939180A1 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase
07/02/2008EP1937677A1 Cb-1 modulating compounds and their use
07/02/2008EP1937675A2 Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals
07/02/2008EP1937673A1 Imidazole derivatives as inhibitors of tafia
07/02/2008EP1937669A1 Novel benzopyran derivatives as potassium channel openers
07/02/2008EP1937664A1 Hydrazide compound and pesticidal use of the same
07/02/2008EP1937658A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
07/02/2008EP1937657A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
07/02/2008EP1937649A1 Imidazole derivatives for the treatment of anxiety and related diseases
07/02/2008EP1937270A1 Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
07/02/2008EP1664041B1 Phenyl-carboxamide compounds useful for treating pain
07/02/2008EP1501808B1 Tachykinin receptor antagonists
07/02/2008EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
07/02/2008CN101213195A Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
07/02/2008CN101213193A Mono-lysine salts of azole compounds
07/02/2008CN101213190A Compounds and compositions as TPO mimetics
07/02/2008CN101213188A Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation
07/02/2008CN101213185A Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
07/02/2008CN101213184A Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
07/02/2008CN101212973A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
07/02/2008CN101212972A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
07/02/2008CN101210013A Lewis acid catalysis aminolysis method for synthesizing piroxicam
07/02/2008CN100398648C Probe foranalysis of nucleic acids
07/02/2008CN100398537C Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
07/02/2008CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5
07/01/2008US7393959 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
07/01/2008US7393867 6-phenylsulfanyl-4H-pyrrolo[2,3-d]thiazole-5-carboxylic acid amide; mood disorders; sleep disorders; major depressive disorder; circadian rhythm sleep disorders; jet lag syndrome; bipolar disorders; reaction with diaryldisulfide or diheteroaryldisulfides to give desired compounds
07/01/2008US7393866 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents
07/01/2008US7393861 Derivatives of 4-aminopiperidine and their use as a medicament
07/01/2008US7393858 Tetrahydropyran compounds as tachykinin antagonists
06/2008
06/26/2008WO2008076883A2 Triazine derivatives and their therapeutical applications
06/26/2008WO2008076860A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
06/26/2008WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/26/2008WO2008075380A2 Process for the preparation of thiazolidine derivatives
06/26/2008WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors
06/26/2008WO2008075064A1 Piperidine derivatives for the treatment of obesity
06/26/2008WO2008075026A1 4-hydr0xy-2-0x0-2, 3 -dihydro- 1, 3-benzothiazol- 7yl compounds for modulation of b2-adrenoreceptor activity
06/26/2008WO2008075019A1 Modulators of cb1 receptors
06/26/2008WO2008074835A1 2-substituted 5-membered heterocycles as scd inhibitors
06/26/2008WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/26/2008WO2008074692A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl )
06/26/2008WO2008074686A1 Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests
06/26/2008WO2008074515A1 Novel hetaryl-phenylene-diamine pyrimidine as protein kinase inhibitors
06/26/2008WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase
06/26/2008WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents
06/26/2008WO2008053360A3 Albumin binding molecules and uses thereof
06/26/2008WO2008043733B1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents
06/26/2008WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives
06/26/2008WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors
06/26/2008WO2007089857A3 Substituted imidazole derivatives and their use as ptpase inhibitors
06/26/2008WO2006108791A3 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
06/26/2008US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole
06/26/2008US20080153895 Macrocyclic indole compounds, e.g., 16-cyclohexyl-3,6-dimethyl-17-phenyl-4,5,6,7,8,9-hexahydro-1H-13,15-(ethanediylidene)pyrrolo[2,1-f][1,2,7,10,13]thiatetraazacyclohexadecine-2,12(3H)-dione 10,10-dioxide; hepatitis C virus polymerase inhibitors
06/26/2008US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
06/26/2008US20080153883 Novel compounds as cannabinoid receptor ligands and uses thereof
06/26/2008US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease
06/26/2008US20080153838 Compounds Having Tie2 (Tek) Activity
06/26/2008US20080153821 Nitrogen-containing 5-membered ring compound
06/26/2008US20080153816 Indole Compounds, Method of Preparing Them and Uses Thereof
06/26/2008US20080153809 Novel amides useful for treating pain
06/26/2008US20080153805 Sulfonamide derivatives
06/26/2008US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators
06/26/2008US20080149175 Merocyanine dyes; solar cells
06/26/2008CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/26/2008CA2673177A1 Modulators of cb1 receptors
06/26/2008CA2673119A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors